Intended Use:
Eloralintide is intended for research purposes only. Reconstitution with bacteriostatic water (BAC water) is required before use.

Storage:
Store lyophilized powder in a cool, dry place away from direct sunlight. After reconstitution, refrigerate at 2–8°C.

Solubility:
Reconstitute with bacteriostatic water. Gently swirl until fully dissolved—do not shake.

Vial Size:
Lyophilized multi-dose vial (commonly supports up to 3ml reconstitution).

Shelf Life:
Lyophilized: up to 24 months
Reconstituted: recommended use within 4–6 weeks.

Handling:
Use sterile techniques during preparation and handling to maintain product stability.

Appetite Regulation Studies
Research suggests that Eloralintide activates amylin receptors to reduce food intake and promote satiety, supporting body weight regulation in preclinical models.

Weight Management Research
Studies have demonstrated sustained reductions in body weight and caloric intake through amylin pathway activation, making Eloralintide a promising candidate in obesity research.

Metabolic Function Studies
Preclinical findings indicate improvements in glucose regulation and energy balance, with potential benefits for overall metabolic health.

Combination Therapy Research
Eloralintide has also been investigated in combination with GLP-1 receptor agonists, where complementary mechanisms may produce greater effects on weight reduction than either pathway alone.

• Eloralintide works by activating amylin receptors, which regulate appetite and metabolic signaling:

  • Activates amylin receptors
    → increases feelings of fullness and reduces food intake
  • Slows gastric emptying
    → prolongs satiety after meals
  • Supports energy balance
    → helps regulate calorie intake and metabolic efficiency
  • Complements GLP-1 pathways
    → provides an additional mechanism for metabolic regulation

  Overall Effect:
  → Reduced appetite + prolonged satiety
  → Improved metabolic regulation and weight management